help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 27, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-1683
A more recent version of this article appeared on May 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/5/1843    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Modan-Moses, D.
Right arrow Articles by Kanety, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Modan-Moses, D.
Right arrow Articles by Kanety, H.

Submitted on August 3, 2006
Accepted on February 20, 2007

MODULATION OF ADIPONECTIN AND LEPTIN DURING REFEEDING OF FEMALE ANOREXIA NERVOSA PATIENTS

Dalit Modan-Moses*, Daniel Stein, Clara Pariente, Amit Yaroslavsky, Anka Ram, Michal Faigin, Ron Loewenthal, Eleanor Yissachar, Rina Hemi, and Hannah Kanety

Pediatric Endocrinology Unit, Pediatric Psychosomatic Department, Institute of Endocrinology, Adult Eating Disorders Department, Tissue Typing Laboratory, Sheba Medical Center, Tel Hashomer, 52621 Israel, affiliated with the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel

* To whom correspondence should be addressed. E-mail: dmodan{at}sheba.health.gov.il.

Context: Several studies assessed adiponectin levels in anorexia nervosa (AN) patients, however, data regarding the dynamics of changes in adiponectin levels during refeeding of these patients is limited and contradicting.

Objective: To assess adiponectin levels and the distribution of its different isoforms in AN patients, before and after long-term refeeding, and to relate them to alterations in body mass index (BMI), leptin, insulin sensitivity and additional endocrine parameters.

Design, setting and participants: Longitudinal controlled study. Thirty eight female adolescent malnourished AN inpatients, and thirteen control, young lean healthy women. Blood samples were obtained upon admission and thereafter at 1, 3, and 5 months (at target weight).

Main outcome measures: Changes in BMI, leptin, adiponectin, insulin sensitivity, and adiponectin multimeric forms.

Results: At admission, leptin levels of AN patients were significantly lower, while insulin sensitivity (assessed by HOMA-IR), adiponectin levels and the ratio of high molecular weight (HMW) adiponectin to total adiponectin were significantly higher compared with controls. During weight recovery, leptin levels and HOMA-IR increased significantly, while adiponectin and HMW adiponectin/total adiponectin ratio decreased significantly, to levels similar to controls. An initial increase in adiponectin levels was observed after one month of refeeding. There was no correlation between adiponectin and either thyroxin or cortisol levels.

Conclusions: our study demonstrates hyperadiponectinemia, increased adiponectin HMW isoform and increased insulin sensitivity in adolescent AN female patients and reversal of these findings with weight rehabilitation. We hypothesize that increased adiponectin levels may have a protective role in maintaining energy homeostasis during extreme malnourishment.


Key words: Anorexia nervosa • Adiponectin • HMW adiponectin • Leptin




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
I. Dostalova, P. Kavalkova, D. Haluzikova, Z. Lacinova, M. Mraz, H. Papezova, and M. Haluzik
Plasma Concentrations of Fibroblast Growth Factors 19 and 21 in Patients with Anorexia Nervosa
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3627 - 3632.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Ibanez, G. Sebastiani, A. Lopez-Bermejo, M. Diaz, M. D. Gomez-Roig, and F. de Zegher
Gender Specificity of Body Adiposity and Circulating Adiponectin, Visfatin, Insulin, and Insulin Growth Factor-I at Term Birth: Relation to Prenatal Growth
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2774 - 2778.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society